myCare Clinical Studies Show Cellworks Singula™ Achieves Superior Therapy Response Predictions for Brain Cancer Patients
Cellworks Multi-omics Biosimulation Delivers GBM and LGG Survival Predictors Above and Beyond…
Cellworks Singula™ Predicts Personalized Therapy Responses for AML and MDS Patients with Higher Accuracy than Physician Prescribed Treatments
myCare Studies Show Cellworks Multi-omics Biosimulation is a Superior Predictor of Complete…
Cellworks Singula™ Predicts Personalized Therapy Responses for Pancreatic Cancer Patients with 94% Accuracy
myCare Study Shows Cellworks Multi-omics Biosimulation is a Superior Predictor of Therapy…
Blood Advances Publishes Cellworks Prospective Genomic Biosimulation Study that Predicts Cancer Therapy Response with 90% Accuracy
Study Uses NGS Data with Biosimulation to Predict Drug Response in AML and MDS Patients
…